MyFinsight
Home
Blog
About
Back
Income Statement
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)
source: myfinsight.com
Net loss and
comprehensive loss
-$17,582K
(76.81%↑ Y/Y)
Product revenue, net
$74,274K
(88.02%↑ Y/Y)
Total other expense
-$13,617K
(14.28%↑ Y/Y)
Loss from operations
-$3,965K
(93.38%↑ Y/Y)
Interest income
$1,510K
(-15.50%↓ Y/Y)
Gross profit
$59,178K
(71.70%↑ Y/Y)
Cost of revenue
$15,096K
(199.64%↑ Y/Y)
Interest expense
$15,103K
(-13.79%↓ Y/Y)
Total operating
expenses
$63,143K
(-33.10%↓ Y/Y)
Other expense, net
-$24K
(84.52%↑ Y/Y)
Selling, general and
administrative
$55,330K
(-35.14%↓ Y/Y)
Research and development
$7,813K
(-13.92%↓ Y/Y)
Back